ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,944Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 387

$2.36M Total Retail Price of All Prescriptions

Rank: 2 out of 387

554 Patients Receiving at Least One Drug in Part D
35%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 554 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

26% of this provider’s 554 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

4% of this provider’s 7,654 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$99 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 925 363 S3 1 1
OMEPRAZOLE 676 213 2 4
LISINOPRIL 583 272 3 3
RISPERIDONE 562 102 4 70
TRAZODONE HCL 549 23 5 37
CITALOPRAM HBR 499 107 6 19
ZOLPIDEM TARTRATE 447 95 7 16
FUROSEMIDE 421 270 8 7
LEVOTHYROXINE SODIUM 420 190 9 2
SIMVASTATIN 418 227 10 5
GABAPENTIN 411 112 11 10
METFORMIN HCL 392 170 12 8
BENZTROPINE MESYLATE 383 21 R 13 167
MIRTAZAPINE 322 23 14 64
POTASSIUM CHLORIDE 317 178 15 9
TRAMADOL HCL 314 84 16 14
ABILIFY 311 18 17 129
INVEGA SUSTENNA 301 0 18 236
FLUOXETINE HCL 285 45 19 46
OLANZAPINE 282 42 20 126
QUETIAPINE FUMARATE 262 16 21 88
DIVALPROEX SODIUM ER 254 15 22 143
POLYETHYLENE GLYCOL 3350 244 119 23 57
SERTRALINE HCL 244 62 23 23
NAMENDA 241 133 25 35
SEROQUEL XR 239 0 26 235
LAMOTRIGINE 239 20 26 138
ROPINIROLE HCL 228 88 28 91
ATENOLOL 219 117 29 20
MELOXICAM 215 77 30 22
DIVALPROEX SODIUM 213 57 31 113
CYMBALTA 209 20 32 44
AMLODIPINE BESYLATE 200 102 33 6
HYDROCHLOROTHIAZIDE 195 54 34 12
PAROXETINE HCL 180 28 35 52
ATORVASTATIN CALCIUM 180 81 35 13
FENTANYL 177 54 S2 37 80
CARISOPRODOL 175 13 R 38 53
DONEPEZIL HCL 173 128 39 27
TAMSULOSIN HCL 166 107 40 32
LANTUS 165 109 41 51
NEXIUM 161 49 42 26
RANITIDINE HCL 161 34 42 45
WARFARIN SODIUM 150 84 44 17
PROAIR HFA 150 18 44 47
HYDROXYZINE PAMOATE 142 0 R 46 258
FAZACLO 142 41 46 191
PHENYTOIN SODIUM EXTENDED 141 41 48 107
ENALAPRIL MALEATE 141 37 48 69
VENLAFAXINE HCL ER 140 0 50 97
METOPROLOL TARTRATE 140 47 50 11
FENOFIBRATE 140 13 50 106
ESCITALOPRAM OXALATE 139 31 53 73
NAPROXEN 131 30 54 89
TOPIRAMATE 130 14 55 140
LISINOPRIL-HYDROCHLOROTHIAZIDE 128 70 56 30
CIPROFLOXACIN HCL 119 55 57 56
CLOZAPINE 118 12 58 185
AMITRIPTYLINE HCL 115 51 R 59 62
SUCRALFATE 111 54 60 128
LEVETIRACETAM 110 22 61 110
CLONIDINE HCL 109 32 62 38
BUPROPION HCL SR 106 17 63 158
VENLAFAXINE HCL 105 18 64 207
PROPRANOLOL HCL 103 26 65 100
SEROQUEL 101 0 66 174
LOVAZA 98 23 67 211
BUSPIRONE HCL 97 0 68 121
IBUPROFEN 95 25 69 85
CLOPIDOGREL 95 55 69 25
LIPITOR 93 33 71 103
JANUVIA 91 63 72 60
SPIRONOLACTONE 89 55 73 67
FLUTICASONE PROPIONATE 88 32 74 29
COMBIVENT 86 14 75 133
PREDNISONE 85 45 76 43
ZETIA 85 78 76 96
CRESTOR 85 41 76 34
MEGESTROL ACETATE 83 73 R 79 123
OXCARBAZEPINE 82 0 80 245
ZYPREXA 82 12 80 320
METOPROLOL SUCCINATE 82 19 80 18
LACTULOSE 79 14 83 153
CELEBREX 79 49 83 72
CYCLOBENZAPRINE HCL 78 26 R 85 42
TIZANIDINE HCL 78 0 85 127
DIGOXIN 78 62 85 40
GEMFIBROZIL 76 20 88 93
CARVEDILOL 75 32 89 21
SINGULAIR 74 26 90 83
FAMOTIDINE 69 26 91 78
MEDROXYPROGESTERONE ACETATE 66 0 92 230
NIASPAN 65 26 93 164
VENTOLIN HFA 65 24 93 142
TRIHEXYPHENIDYL HCL 65 12 R 93 335
PREMARIN 63 33 R 96 77
CARBAMAZEPINE XR 63 0 96 294
DOXAZOSIN MESYLATE 62 34 98 75
OXYCODONE HCL-ACETAMINOPHEN 62 0 S2 98 98
ACTOS 61 40 100 99
CARBAMAZEPINE 61 14 100 238
LOSARTAN POTASSIUM 61 35 100 24
DIOVAN 60 34 103 33
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 32 104 90
KLOR-CON 10 58 36 104 124
PANTOPRAZOLE SODIUM 57 0 106 48
OXYCODONE HCL 57 0 S2 106 71
PROMETHAZINE HCL 56 26 R 108 82
ZIPRASIDONE HCL 55 0 109 292
LEVOFLOXACIN 54 32 110 84
LITHIUM CARBONATE 53 0 111 267
PLAVIX 53 35 111 39
LATUDA 52 11 113 368
LYRICA 52 29 113 66
CHLORPROMAZINE HCL 52 12 113 306
SAPHRIS 52 0 113 368
CEPHALEXIN 51 0 117 135
PRAVASTATIN SODIUM 51 34 117 15
KETOCONAZOLE 51 25 117 373
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.